AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $340,480 | -3.2% | 28,000 | 0.0% | 0.29% | +9.8% |
| Q2 2023 | $351,680 | +112980.4% | 28,000 | 0.0% | 0.26% | +8.6% |
| Q1 2023 | $311 | -9.1% | 28,000 | 0.0% | 0.24% | +0.4% |
| Q4 2022 | $342 | -99.9% | 28,000 | -26.3% | 0.24% | -13.6% |
| Q3 2022 | $397,000 | -2.7% | 38,000 | 0.0% | 0.28% | -5.7% |
| Q2 2022 | $408,000 | +13.3% | 38,000 | 0.0% | 0.30% | +14.7% |
| Q1 2022 | $360,000 | -18.0% | 38,000 | 0.0% | 0.26% | -8.5% |
| Q4 2021 | $439,000 | +20.9% | 38,000 | 0.0% | 0.28% | +14.6% |
| Q3 2021 | $363,000 | -0.8% | 38,000 | 0.0% | 0.25% | +12.8% |
| Q2 2021 | $366,000 | -2.4% | 38,000 | 0.0% | 0.22% | -1.8% |
| Q1 2021 | $375,000 | -57.2% | 38,000 | 0.0% | 0.22% | -55.8% |
| Q4 2020 | $877,000 | -18.3% | 38,000 | -50.0% | 0.50% | +40.7% |
| Q3 2020 | $1,074,000 | +87.4% | 76,000 | +100.0% | 0.36% | +3.8% |
| Q2 2020 | $573,000 | +63.2% | 38,000 | 0.0% | 0.35% | +11.3% |
| Q1 2020 | $351,000 | -5.1% | 38,000 | 0.0% | 0.31% | +15.6% |
| Q4 2019 | $370,000 | +21.3% | 38,000 | 0.0% | 0.27% | +32.5% |
| Q3 2019 | $305,000 | -35.7% | 38,000 | 0.0% | 0.20% | -29.5% |
| Q2 2019 | $474,000 | -8.3% | 38,000 | 0.0% | 0.29% | -11.1% |
| Q1 2019 | $517,000 | +42.0% | 38,000 | 0.0% | 0.32% | -5.8% |
| Q4 2018 | $364,000 | -20.7% | 38,000 | 0.0% | 0.34% | +16.2% |
| Q3 2018 | $459,000 | -13.6% | 38,000 | +11.8% | 0.30% | -18.0% |
| Q2 2018 | $531,000 | +3.9% | 34,000 | 0.0% | 0.36% | +7.1% |
| Q1 2018 | $511,000 | +254.9% | 34,000 | +240.0% | 0.34% | +301.2% |
| Q4 2017 | $144,000 | -4.6% | 10,000 | 0.0% | 0.08% | +7.7% |
| Q3 2017 | $151,000 | – | 10,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |